Bio Green Med Solution, Inc.

Bio Green Med Solution maintains a highly liquid balance sheet with $3.34 million in cash and equivalents against $0.80 million in total liabilities, resulting in a current ratio of 7.06. The company carries zero debt, evidenced by a debt-to-equity ratio of 0.0, and holds a market capitalization of $4.83 million. Despite strong liquidity, the firm trades at a price-to-book ratio of 0.93, reflecting a discount to its $6.76 million in total equity. The capital structure is complex, featuring multiple series of convertible preferred stock and warrants, which introduces potential dilution risks despite the absence of traditional interest-bearing debt.

Profitability remains negative, with Q1 2026 net income at -$0.20 million and operating income at -$0.25 million on $0.74 million in revenue. Return on equity stands at -44.35% and return on assets at -39.64%, indicating significant erosion of shareholder value. The company generated negative operating cash flow of -$0.28 million and negative free cash flow of -$0.29 million in the quarter. These metrics suggest the business is currently cash-burning, relying on its existing cash reserves and potential equity issuances to fund operations rather than generating internal returns.

Revenue generation is concentrated in a single reportable segment, with activities spanning fire safety equipment, safety apparel, maintenance and servicing, and project supply and installation. Geographic exposure includes the United States, Malaysia, and the United Kingdom, as indicated by filing data. Customer concentration is high, with the top four customers accounting for 55% of total sales in the 2025 fiscal year. This concentration creates dependency risk, as the loss of a major client could materially impact revenue stability.

Growth trajectory is obscured by consistent operating losses and a history of negative net income. The company reported a net loss of -$0.197 million in Q1 2026, compared to a loss of -$0.081 million in the same period of the prior year, indicating an expansion in losses. Revenue of $0.74 million in Q1 2026 provides a baseline, but the lack of positive earnings growth and the reliance on capital raises to sustain operations suggest a precarious growth path. The company has not demonstrated a clear trend toward profitability or organic revenue expansion sufficient to offset its cash burn.

Risk factors are elevated, with filings referencing going-concern or substantial-doubt language. The company faces medium dilution risk due to the presence of convertible preferred stock, warrants, and stock-based compensation. Liquidity risk is assessed as high, likely due to the reliance on external capital to cover operating deficits. Additionally, the company is approaching a NASDAQ minimum-bid deficiency, having closed below $1.00 for 20 consecutive trading days, which threatens its continued listing status. Regulatory and compliance risks are present, including adherence to Nasdaq listing requirements and US securities laws.

Recent events include the issuance of common stock and preferred stock through various securities purchase agreements and warrant exercises. The company engaged in multiple financing activities, including the issuance of Series C, D, and E preferred stock, and the exercise of pre-funded warrants. These actions highlight the company's ongoing need for capital. The news observations note the approaching NASDAQ listing deficiency, adding urgency to the company's financial and operational challenges. The filing observations detail complex equity transactions, including conversions of preferred stock and the issuance of new shares, which contribute to the dilution risk.

The company maintains a zero debt-to-equity ratio, indicating a conservative capital structure with no long-term debt obligations.

Operating losses narrowed significantly from $25.5 million in FY2023 to $8.4 million in FY2025, demonstrating improved cost management.

The stock trades at a price-to-book ratio of 0.93, suggesting the market values the company below its tangible book value.

A current ratio of 4.70 indicates strong short-term liquidity, providing a buffer against immediate financial obligations.

The company faces high liquidity risk, potentially threatening its ability to meet short-term financial obligations and operational needs.

Revenue $743.0k; Operating income -$246.0k.

• ▍Revenue $743.0k
• ▍Operating income -$246.0k
• ▍Net margin -26.5%

Operating income -$7.3M.

• ▍Operating income -$7.3M

Revenue $0.00; Operating income -$8.4M.

• ▍Revenue $0.00
• ▍Operating income -$8.4M

Revenue $43.0k; Operating income -$12.0M.

• ▍Revenue $43.0k
• ▍Operating income -$12.0M
• ▍Net margin -26074.4%

Operating income -$12.0M.

• ▍Operating income -$12.0M

Operating income -$25.5M.

• ▍Operating income -$25.5M